Evelina Tacconelli to receive ESCMID Lifetime Achievement Award
Ecraid Chief Scientific Officer Evelina Tacconelli will receive the prestigious 2024 ESCMID Lifetime Achievement Award in recognition of her exceptional contributions to the fields of infectious diseases and clinical microbiology.
The ESCMID Lifetime Achievement Award honours a deserving member for their outstanding contribution to the ESCMID mission, which is to champion medical progress in infection for a healthier tomorrow. Evelina will receive the award during the opening ceremony of ESCMID Global on 27 April 2024.
On the following day, she will deliver a distinguished lecture titled How can current rapid diagnostic tests support antibiotic stewardship?
I am honoured to receive this Lifetime Achievement Award. ESCMID's mission, to improve infection management and advance science, means a lot to me and is at the heart of my work and that of my colleagues in Verona: producing high-level scientific evidence in the field of infectious diseases to improve the care of patients. Nothing is more important than this.
Biography
Evelina Tacconelli is the Director of the Infectious Diseases Section at Verona University Hospital, Italy, and serves as the Senior Consultant on Antimicrobial Resistance at the Department of Internal Medicine, DZIF Clinical Research Unit at the University of Tübingen, Germany.
Evelina coordinated on the 2017 Priority Pathogen List for new, effective antibiotics for R&D with the WHO, and served as consultant for the WHO and ECDC (European Centre for Disease Prevention and Control) in the field of antimicrobial stewardship and infection control. She currently coordinates the CTS OPERA Working Group on optimising antibiotics prescriptions for AIFA, the Italian Medicine Agency, as well as the Cohort Coordination Board, which links major European projects with a cohort design assessing infectious diseases with pandemic potential.
Under her leadership, her teams have actively participated in and coordinated numerous European projects and networks focused on clinical and epidemiological aspects of antimicrobial-resistant infections and SARS-CoV-2 infection, including the ORCHESTRA project. Evelina’s significant research contributions are encapsulated in over 300 peer-reviewed publications.
Previous Ecraid-affiliated recipients of ESCMID awards include:
- Ecraid co-founder Herman Goossens received the prestigious ESCMID Award for Excellence in Clinical Microbiology and Infectious Diseases in 2020.
- Ecraid CEO Marc Bonten received the distinguished ESCMID Award for Excellence in Clinical Microbiology and Infectious Diseases in 2015.
Visit us at ESCMID Global 2024
ESCMID Global is a four-day clinical microbiology and infectious diseases congress, which takes place from 27 April to 30 April. The European Society of Clinical Microbiology & Infectious Diseases (ESCMID) stands as the foremost society for Clinical Microbiology and Infectious Diseases in Europe. Read more about Ecraid’s booth and our activities here.